BET Pharm ensures you'll
One key component of any successful business venture is its ability to differentiate itself from the competition. BET Pharm’s use of BioRelease™ state of the art delivery platforms to deliver many of the actives we compound has dramatically improved compliance for the veterinary practitioner. Many formulations are tested in-vitro and in-vivo to enhance quality. Moreover, independent research trials conducted at US, British, Argentine, and Brazilian Universities have consistently demonstrated the proven efficacy of numerous compounds when administered in BioRelease™ vehicles.
BET PHARM maintains strict quality control. All injectables undergo rigorous sterility testing. We adhere to external quality control monitoring by independent labs, such as Analytical Research Laboratories for stability, pyrogens, purity and verification of prescribed potency as well as our adherence to standards set forth in the 797 guidelines. Our quality assurance program is designed to ensure every prescription meets your specifications. Our pharmacists have extensive training in compounding procedures and utilize a class 100/ ISO 5 cleanroom to prepare our compounds in our state-licensed facility. When you choose BET Pharm you can be confident your patients will receive medications of the highest quality.
Please join over 5000 of your veterinary colleagues who use BET Pharm as their compounding pharmacy when unique formulations and delivery systems are needed to improve patient compliance.
Who We Are
BET Pharm was established in 2002 as a privately held company to fill the need of the equine breeding industry in formulating controlled-release compounded reproductive hormones.
The pharmacy shares a history with another company established by the same founders; BioRelease Technologies (BRT). BRT conducts innovative research and development in the area of proprietary controlled-release formulations for the animal health industry with an emphasis on the development of more efficacious medical treatment and therapies.
BET Pharm brings together the fields of equine reproductive research, academia and compounding pharmacy to provide a unique experience for its clients. The pharmacy staff at BET all have a passion for horses and genuinely care for our clients and their animals.
BET Pharm opens a state of the art facility that launches the pharmacy to new heights giving it more space and a better workflow to continue to provide the equine industry with unique long-acting formulas.
BRT Australasia opens a compounding facility in Melbourne Australia that also compounds an array of long-acting reproductive hormones for the equine industry.
BioRelease Technologies (BRT) is founded by Dr. Patrick Burns, Richard Gilley and Dr. Robert Douglas. Each scientist brings together their respective fields of equine reproduction research and controlled-release technology to develop innovative formulations. That same year BET Pharm is established and licenses the BioRelease technology to compound unique long-acting reproductive hormones.
Dr. Douglas co-founded BET Laboratories, which continues to be a leading veterinary endocrine diagnostic laboratory. This laboratory was expanded to Brasil (1999) and continues to be a leader in veterinary endocrine diagnostics in that country.
Dr. Robert Douglas, an assistant professor of Veterinary Science at both Michigan State University (1975-78) and the University of Kentucky (1978-84), found Bluegrass Embryo Transplants (BET).